Table 2.
LCMSMS Data | |||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Case No. |
Year | Sex | Age | GA | BW (g) |
1st Tier 17OHP |
2nd Tier 17OHP Immuno |
Protocol 1 Screening Result |
17OHP | 21DF | Protocol 2 Screening Result |
12 | 2017 | M | 3 | 37 | 3010 | 278 | 140 | Positive | 95 | 5 | Positive |
13 | 2014 | M | 3 | 41 | 4330 | 401 | 326 | Positive | 232 | 6 | Positive |
14 | 2014 | F | 3 | 41 | 3750 | 319 | 93 | Positive | 46 | 3 | Positive |
15 | 2013 | F | 3 | 38 | 3610 | 209 | 179 | Positive | 114 | 2 | Positive |
16 | 2013 | F | 1 | 36 | 2580 | 91 | 38 | Positive | 20 | 19 | Positive |
17 | 2013 | F | 1 | 41 | 4200 | 242 | 211 | Positive | 212 | 209 | Positive |
18 | 2012 | F | 2 | 40 | 3650 | 211 | 160 | Positive | 61 | 14 | Positive |
19 | 2012 | M | 4 | 40 | 3165 | 69 | 53 | Positive | 36 | 10 | Positive |
20 | 2012 | F | 1 | 40 | 4100 | 108 | 56 | Positive | 44 | 11 | Positive |
21 | 2011 | M | 3 | 39 | 2970 | 207 | 142 | Positive | 84 | 10 | Positive |
22 | 2010 | F | 1 | 34 | 2410 | 295 | 239 | Positive | 158 | 34 | Positive |
23 | 2010 | F | 0 | 38 | - | 144 | 111 | Positive | 76 | 24 | Positive |
24 | 2010 | F | 1 | 39 | 3710 | 305 | 131 | Positive | 73 | 44 | Positive |
25 | 2009 | M | 2 | 31 | 1810 | 354 | 305 | Positive | 194 | 38 | Positive |
26 | 2009 | F | 5 | 40 | 3200 | 301 | 201 | Positive | 268 | 47 | Positive |
27 | 2008 | M | 4 | 40 | 3750 | 135 | 66 | Positive | 42 | 2 | Positive |
28 | 2008 | M | 3 | - | 4340 | 282 | 63 | Positive | 39 | 19 | Positive |
29 | 2008 | M | 2 | 39 | 3350 | 255 | 186 | Positive | 97 | <2 | Positive |
30 | 2008 | F | 2 | 41 | 3605 | 326 | 267 | Positive | 115 | 66 | Positive |
31 | 2007 | F | 3 | - | 4360 | 248 | 215 | Positive | 86 | 38 | Positive |
32 | 2007 | M | 2 | 41 | 4330 | 415 | 185 | Positive | 81 | 21 | Positive |
33 | 2006 | M | 3 | 40 | 3620 | 404 | 575 | Positive | 326 | 9 | Positive |
34 | 2006 | F | 3 | 42 | 3230 | 123 | 66 | Positive | 33 | 48 | Positive |
35 | 2005 | F | 2 | 39 | 3340 | 444 | 285 | Positive | 160 | 12 | Positive |
36 | 2005 | F | 4 | - | 3760 | 127 | 67 | Positive | 41 | 16 | Positive |
CAH Cases Not Detected by Screening | |||||||||||
37 | 2014 | M | 4 | - | 4770 | 30 | 17 | Negative | 30 | 5 | Positive |
38 | 2010 | F | 4 | 38 | 2930 | 72 | 19 | Negative | 19 | 13 | Positive |
39 | 2010 | M | 2 | - | 3655 | 34 | 17 | Negative | 8 | 7 | Positive |
40 | 2009 | F | 3 | 40 | 3360 | 30 | 21 | Negative | 12 | 11 | Positive |
41 | 2015 | F | 2 | 39 | 3450 | 5 | - | Negative | 2 | <2 | Negative |
42 | 2015 | M | 3 | 39 | 3770 | 26 | - | Negative | 12 | 10 | Negative * |
43 | 2012 | F | 4 | 39 | 3640 | 13 | - | Negative | 6 | <2 | Negative |
44 | 2010 | F | 3 | 40 | 3110 | 6 | - | Negative | 1 | <2 | Negative |
45 | 2008 | F | 5 | 31 | 1640 | 4 | - | Negative | 2 | <2 | Negative |
46 | 2006 | F | 3 | 40 | 3530 | 11 | Negative | 4 | <2 | Negative | |
Laboratory Screening Cut-offs | ≥27 | ≥23 | ≥27 | ≥3 |
* Case 42 is a negative screening result using protocol 2 as the specimen would not reflex to second-tier testing.